Inventor
GOETSCH LILIANE
FR44 patents
⚠️ This page may combine multiple inventors who share the name “GOETSCH LILIANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GOETSCH LILIANE
23 patentsUS8329173B2Dec 11, 2012
Antibodies inhibiting c-Met dimerization and uses thereof
GOETSCH LILIANE24 citations92
US8741290B2Jun 3, 2014
Anti-cMet antibody
GOETSCH LILIANE15 citations90
US8545839B2Oct 1, 2013
Anti-c-Met antibody
GOETSCH LILIANE20 citations90
US9107907B2Aug 18, 2015
Antibodies inhibiting c-Met dimerization, and uses thereof
GOETSCH LILIANE6 citations84
US8889832B2Nov 18, 2014
Antibodies inhibiting c-Met dimerization, and uses thereof
GOETSCH LILIANE6 citations84
US8871910B2Oct 28, 2014
Antibodies inhibiting c-Met dimerization, and uses thereof
GOETSCH LILIANE6 citations84
US8871909B2Oct 28, 2014
Antibodies inhibiting c-Met dimerization and uses thereof
GOETSCH LILIANE6 citations84
US8124079B2Feb 28, 2012
Anti-IGF-IR antibodies and uses thereof
GOETSCH LILIANE8 citations84
US8673302B2Mar 18, 2014
Anti-cMet antibody and its use for the detection and the diagnosis of cancer
GOETSCH LILIANE9 citations83
US9469691B2Oct 18, 2016
Anti-cMET antibody
GOETSCH LILIANE8 citations82
US8765128B2Jul 1, 2014
Anti-cMET antibody
GOETSCH LILIANE8 citations82
US8747850B2Jun 10, 2014
Anti-cMET antibody
GOETSCH LILIANE6 citations82
US8729249B2May 20, 2014
Anti-cMET antibody
GOETSCH LILIANE4 citations82
US8071730B2Dec 6, 2011
Anti-JAM-A antibodies
GOETSCH LILIANE7 citations82
US9375425B2Jun 28, 2016
Combination of a C-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
GOETSCH LILIANE4 citations73
US8623359B2Jan 7, 2014
Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
GOETSCH LILIANE4 citations73
US8168410B2May 1, 2012
Anti-IGF-IR antibodies and uses thereof
GOETSCH LILIANE4 citations73
US8101180B2Jan 24, 2012
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
GOETSCH LILIANE5 citations73
US8420085B2Apr 16, 2013
Anti-IGF-IR antibodies and uses thereof
GOETSCH LILIANE0 citations52
US8808667B2Aug 19, 2014
Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
GOETSCH LILIANE0 citations51
US8808999B2Aug 19, 2014
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
GOETSCH LILIANE0 citations51
US8241646B2Aug 14, 2012
Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
GOETSCH LILIANE0 citations51
US9676839B2Jun 13, 2017
Process for the modulation of the antagonistic activity of a monoclonal antibody
GOETSCH LILIANE0 citations40
PF MEDICAMENT
18 patentsUS7241444B2Jul 10, 2007
Anti-IGF-IR antibodies and uses thereof
PF MEDICAMENT95 citations97
US7553485B2Jun 30, 2009
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
PF MEDICAMENT18 citations92
US9011865B2Apr 21, 2015
Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
PF MEDICAMENT6 citations84
US8361461B2Jan 29, 2013
Anti-IGF-IR antibodies and uses thereof
PF MEDICAMENT8 citations84
US7914784B2Mar 29, 2011
Anti-IGF-IR antibodies and uses thereof
PF MEDICAMENT10 citations83
US10202458B2Feb 12, 2019
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer
PF MEDICAMENT9 citations82
US7854930B2Dec 21, 2010
Anti-igf-ir antibodies and uses thereof
PF MEDICAMENT7 citations73
US11365259B2Jun 21, 2022
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer
PF MEDICAMENT2 citations71
US11219693B2Jan 11, 2022
Antibody-drug-conjugate and its use for the treatment of cancer
PF MEDICAMENT1 citations71
US10633448B2Apr 28, 2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer
PF MEDICAMENT4 citations71
US10314921B2Jun 11, 2019
Antibody-drug-conjugate and its use for the treatment of cancer
PF MEDICAMENT3 citations71
US10858423B2Dec 8, 2020
Composition for the treatment of IGF-1R expressing cancer
PF MEDICAMENT3 citations70
US10161930B2Dec 25, 2018
Antigen binding protein and its use as addressing product for the treatment of cancer
PF MEDICAMENT1 citations62
US11661457B2May 30, 2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer
PF MEDICAMENT0 citations60
US9689862B2Jun 27, 2017
Antigen binding protein and its use as addressing product for the treatment of cancer
PF MEDICAMENT1 citations60
US8945871B2Feb 3, 2015
Anti-IGF-IR antibodies and uses thereof
PF MEDICAMENT0 citations52
US9669106B2Jun 6, 2017
Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer
PF MEDICAMENT0 citations51
US9624308B2Apr 18, 2017
Antigen binding proteins
PF MEDICAMENT1 citations50